Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Country | Sampling frame/type of study | ||
---|---|---|---|
Belgium | Small seizures (mostly at user's level)/judicial cases analysed in the framework of the project 'Composition of drugs in circulation'. | ||
Bulgaria | All seizures/routine analysis of seizures. | ||
Czech Republic | All seizures (analysed in Prague and 3 out of 7 regional police laboratories)/routine analysis of seizures. | ||
Germany | All seizures/routine analysis of seizures. | ||
Estonia | All seizures which weight more than 9 g./routine analysis of seizures. | ||
France-A | All seizures/routine analysis of seizures. | ||
France-B | User's level: local sampling/ad hoc study. | ||
Luxembourg | All seizures/routine analysis of seizures. | ||
Hungary | All seizures submitted for analysis of over 5 g. for cannabis resin/routine analysis of seizures. | ||
Malta | All seizures/routine analysis of seizures. | ||
The Netherlands | User's level: random test purchases in coffee shops/monitoring system. | ||
Austria | All seizures/routine analysis of seizures. | ||
Poland | Not all seizures (but includes material from cannabis cultivations)/routine analysis of seizures. | ||
Portugal | All seizures/routine analysis of seizures. | ||
Slovakia | All seizures/routine analysis of seizures. | ||
UK (England and Wales) | All seizures, purchases/routine analysis of seizures. |
Page last updated: Tuesday, 13 November 2007